Status: Recruiting
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial and popliteal arterial disease.
Participants needed: 279
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Concept Medical Inc.Updated: Jul 3, 2025Locations: 20
Eligibility criteria
Age ≥ 21 years or minimum age [+4]
Comorbid conditions limiting life expectancy ≤ 1 year [+14]